This work is licensed under a Creative Commons Attribution 4.0 International License.
LT-E2H5
General Information
DRACP ID DRACP06091
Peptide Name LT-E2H5
Sequence FEAVHLLA
Sequence Length 8
UniProt ID Not available
PubChem CID Not available
Origin Synthetic (Derived from SLIT2 protein)
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C43H66N10O11
Absent amino acids CDGIKMNPQRSTWY
Common amino acids AL
Mass 102411
Pl 5.36
Basic residues 1
Acidic residues 1
Hydrophobic residues 6
Net charge 0
Boman Index 901
Hydrophobicity 143.75
Aliphatic Index 158.75
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN111032679A
Patent Title Peptides for Cancer Treatment
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.